Institutions / Catalio Capital Management, LP / Holdings
Back to Catalio Capital Management, LP

Catalio Capital Management, LP

All holdings · as of Dec 31, 2025

45 positions

CompanyClassValue ↓Shares% of portfolio
GILEAD SCIENCES, INC.—$35.51M289,3126.3%
BRISTOL MYERS SQUIBB CO—$34.95M647,8996.2%
BOSTON SCIENTIFIC CORP—$34.37M360,4286.1%
BridgeBio Oncology Therapeutics, Inc.BBOTCommon Stock$31.41M410,7005.6%
ELI LILLY & Co—$27.86M25,9234.9%
Dianthus Therapeutics, Inc.—$26.93M653,5724.8%
ASCENDIS PHARMA A/S—$25.43M119,2654.5%
Syndax Pharmaceuticals Inc—$25.14M1,196,8074.4%
JOHNSON & JOHNSON—$25.01M120,8404.4%
REGENERON PHARMACEUTICALS, INC.—$23.00M29,7974.1%
Structure Therapeutics Inc.GPCRADR$17.59M252,9013.1%
SOLENO THERAPEUTICS, INC.—$16.68M360,3402.9%
Cytokinetics Inc—$16.42M258,3812.9%
Edwards Lifesciences Corp—$15.95M187,0482.8%
Intuitive Surgical Inc—$15.41M27,2092.7%
Natera, Inc.—$14.27M62,2732.5%
Adaptive Biotechnologies Corp—$13.34M821,1952.4%
ABIVAX SA—$13.29M98,5142.3%
Supernus Pharmaceuticals Inc—$12.80M257,4652.3%
FRACTYL HEALTH, INC.GUTSCommon Stock$12.08M5,491,8662.1%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$12.04M331,8492.1%
Phathom Pharmaceuticals, Inc.PHATCommon Stock$11.60M698,9962.0%
ADMA Biologics Inc—$10.30M564,4611.8%
Arcellx, Inc.—$10.18M156,1091.8%
Dyne Therapeutics, Inc.—$10.17M519,7151.8%
Disc Medicine, Inc.IRONCommon Stock$8.77M110,4271.5%
Ocular Therapeutix, Inc—$8.67M714,5011.5%
Septerna, Inc.SEPNCommon Stock$8.21M294,3601.5%
Protara Therapeutics, Inc.—$7.71M1,446,2541.4%
UNIQURE NV—$6.90M288,3451.2%
Olema Pharmaceuticals, Inc.—$6.68M267,0581.2%
Terns Pharmaceuticals, Inc.—$5.53M136,9581.0%
Ultragenyx Pharmaceutical Inc.—$3.74M162,5500.7%
Heartflow, Inc.—$3.32M113,8570.6%
GRAIL, Inc.—$2.59M30,3130.5%
Fulcrum Therapeutics, Inc.—$2.28M201,3010.4%
BillionToOne, Inc.BLLNCommon Stock$2.09M25,5050.4%
Eledon Pharmaceuticals, Inc.—$1.90M1,259,8200.3%
Hyperfine, Inc.HYPRCommon Stock$1.29M1,320,0410.2%
PALVELLA THERAPEUTICS, INC.PVLACommon Stock$1.09M10,4520.2%
Karyopharm Therapeutics Inc.—$1.05M142,9840.2%
Metagenomi Therapeutics, Inc.MGXCommon Stock$857.0K528,9930.2%
ATAI BECKLEY NV—$805.1K196,8580.1%
Outset Medical, Inc.—$438.8K118,2790.1%
Sensei Biotherapeutics, Inc.—$157.0K14,7180.0%
← PrevPage 1 of 1Next →